BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23936523)

  • 1. Interleukin expression after injury and the effects of interleukin-1 receptor antagonist.
    Chamberlain CS; Leiferman EM; Frisch KE; Brickson SL; Murphy WL; Baer GS; Vanderby R
    PLoS One; 2013; 8(8):e71631. PubMed ID: 23936523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury.
    Chamberlain CS; Leiferman EM; Frisch KE; Duenwald-Kuehl SE; Brickson SL; Murphy WL; Baer GS; Vanderby R
    Connect Tissue Res; 2014 Jun; 55(3):177-86. PubMed ID: 24649870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles Locally Deliver Active Interleukin-1 Receptor Antagonist In Vivo.
    Clements AEB; Groves ER; Chamberlain CS; Vanderby R; Murphy WL
    Adv Healthc Mater; 2018 Aug; 7(16):e1800263. PubMed ID: 29974661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing.
    Saether EE; Chamberlain CS; Aktas E; Leiferman EM; Brickson SL; Vanderby R
    Stem Cell Rev Rep; 2016 Feb; 12(1):42-53. PubMed ID: 26530282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of macrophage depletion on ligament healing.
    Chamberlain CS; Leiferman EM; Frisch KE; Wang S; Yang X; van Rooijen N; Baer GS; Brickson SL; Vanderby R
    Connect Tissue Res; 2011 Jun; 52(3):203-11. PubMed ID: 21117894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of interleukin-4 on ligament healing.
    Chamberlain CS; Leiferman EM; Frisch KE; Wang S; Yang X; Brickson SL; Vanderby R
    Wound Repair Regen; 2011; 19(3):426-35. PubMed ID: 21518087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
    Yamada J; Dana MR; Sotozono C; Kinoshita S
    Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages.
    Yanagawa H; Sone S; Haku T; Mizuno K; Yano S; Ohmoto Y; Ogura T
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):71-6. PubMed ID: 7811472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation.
    Ruth JH; Bienkowski M; Warmington KS; Lincoln PM; Kunkel SL; Chensue SW
    J Immunol; 1996 Apr; 156(7):2503-9. PubMed ID: 8786311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene profiling of the rat medial collateral ligament during early healing using microarray analysis.
    Chamberlain CS; Brounts SH; Sterken DG; Rolnick KI; Baer GS; Vanderby R
    J Appl Physiol (1985); 2011 Aug; 111(2):552-65. PubMed ID: 21596919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia.
    Eik W; Marcon SS; Krupek T; Previdelli IT; Pereira OC; Silva MA; Bazotte RB
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study.
    Hildebrand KA; Woo SL; Smith DW; Allen CR; Deie M; Taylor BJ; Schmidt CC
    Am J Sports Med; 1998; 26(4):549-54. PubMed ID: 9689377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury location affects ligament healing. A morphologic and mechanical study of the healing rabbit medial collateral ligament.
    Frank CB; Loitz BJ; Shrive NG
    Acta Orthop Scand; 1995 Oct; 66(5):455-62. PubMed ID: 7484130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes.
    Wang F; Liu J; Chen X; Zheng X; Qu N; Zhang B; Xia C
    Arthritis Res Ther; 2019 Jul; 21(1):171. PubMed ID: 31291980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist attenuates tumor necrosis factor-induced alterations in wound breaking strength.
    Maish GO; Shumate ML; Ehrlich HP; Vary TC; Cooney RN
    J Trauma; 1999 Sep; 47(3):533-7. PubMed ID: 10498310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalization of the inflammatory response to inhaled grain dust.
    Becker S; Clapp WA; Quay J; Frees KL; Koren HS; Schwartz DA
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1309-18. PubMed ID: 10508823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of interleukin-1beta and interleukin-1 receptor antagonist in an antigen-induced arthritis of the rabbit temporomandibular joint.
    Habu M; Tominaga K; Sukedai M; Alstergren P; Ohkawara S; Kopp S; Fukuda J
    J Oral Pathol Med; 2002 Jan; 31(1):45-54. PubMed ID: 11896822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.
    Luhm J; Langenkamp U; Hensel J; Frohn C; Brand JM; Hennig H; Rink L; Koritke P; Wittkopf N; Williams DL; Mueller A
    BMC Immunol; 2006 Mar; 7():5. PubMed ID: 16553947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.